Osamu Nagayama
Osamu Nagayama (born April 21, 1947) is the chairman and chief executive officer of Chugai Pharmaceutical Co., one of Japan's largest drug companies.[1][2][3][4][5][6][7]
Osamu Nagayama | |
---|---|
![]() Osamu Nagayama (lower right) with the Board of Directors of the ICMEC | |
Born | April 21, 1947 |
Alma mater | Keio University |
Occupation | Chairman and chief executive officer of Chugai Pharmaceutical Co. Chairman of the board of directors, Sony Corporation |
He served as chairman of the board of directors of Sony Corporation from 2013 to 2019.[4][8]
Nagayama is Japanese.[6] He obtained his bachelor's degree from Keio University in 1971, where he studied in the Faculty of Business and Commerce.[5][6] He began his professional career in 1971 at the Long-Term Credit Bank of Japan.[6] He joined Chugai Pharmaceutical Co., Ltd., in November 1978.[6][7]
Nagayama is a member of the board of directors of the International Centre for Missing & Exploited Children (ICMEC), a global nonprofit organization that combats child sexual exploitation, child pornography, and child abduction.[9]
Preceded by Howard Stringer |
Chairman of the Board of Sony Corporation June 20, 2013–June 18, 2019 |
Succeeded by Shuzo Sumi |
References
- Conflicts of Interest and the Future of Medicine: The United States, France and Japan. 2011.
- George Olcott (2009). Conflict and Change: Foreign Ownership and the Japanese Firm. Cambridge University Press.
- "Volume 173, Issues 1–3". Forbes. 2004.
- "Osamu Nagayama: Executive Profile & Biography". Business Week.
- "Osamu Nagayama". Bloomberg.
- "Roche – Osamu Nagayama". roche.com. Archived from the original on 2015-02-04. Retrieved 2015-02-04.
- "NOTICE OF CONVOCATION OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS FOR THE BUSINESS TERM ENDED DECEMBER 31, 2007"
- "Sony Corporation Executive Appointments". Sony.
- "ICMEC Board Members". ICMEC. Archived from the original on 2015-07-03.